Complications and Comorbidities of Acromegaly—Retrospective Study in Polish Center
Open Access
- 16 March 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12
Abstract
Introduction: In acromegaly, chronic exposure to impaired GH and IGF-I levels leads to the development of typical acromegaly symptoms, and multiple systemic complications as cardiovascular, metabolic, respiratory, endocrine, and bone disorders. Acromegaly comorbidities contribute to decreased life quality and premature mortality. The aim of our study was to assess the frequency of acromegaly complications and to evaluate diagnostic methods performed toward recognition of them. Materials and Methods: It was a retrospective study and we analyzed data of 179 patients hospitalized in the Department of Endocrinology, Diabetes and Isotope Therapy in Wroclaw Medical University (Poland) in 1976 to 2018 to create a database for statistical analysis. Results: The study group comprised of 119 women (66%) and 60 men (34%). The median age of acromegaly diagnosis was 50.5 years old for women (age range 20–78) and 46 for men (range 24–76). Metabolic disorders (hyperlipidemia, diabetes, and prediabetes) were the most frequently diagnosed complications in our study, followed by cardiovascular diseases and endocrine disorders (goiter, pituitary insufficiency, osteoporosis). BP measurement, ECG, lipid profile, fasting glucose or OGTT were performed the most often, while colonoscopy and echocardiogram were the least frequent. Conclusions: In our population we observed female predominance. We revealed a decrease in the number of patients with active acromegaly and an increase in the number of well-controlled patients. More than 50% of patients demonstrated a coexistence of cardiac, metabolic and endocrine disturbances and only 5% of patients did not suffer from any disease from those main groups.Keywords
This publication has 47 references indexed in Scilit:
- Risk of Thyroid Nodular Disease and Thyroid Cancer in Patients with Acromegaly – Meta-Analysis and Systematic ReviewPLOS ONE, 2014
- Epidemiología de la acromegalia en EspañaEndocrinología y Nutrición, 2013
- Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databasesPituitary, 2013
- Vertebral Fractures in Patients With Acromegaly: A 3-Year Prospective StudyThe Journal of Clinical Endocrinology & Metabolism, 2013
- Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly RegisterEuropean Journal of Endocrinology, 2013
- A consensus on the diagnosis and treatment of acromegaly complicationsPituitary, 2012
- Predictors of morbidity and mortality in acromegaly: an Italian surveyEuropean Journal of Endocrinology, 2012
- Mortality in Patients with Pituitary DiseaseEndocrine Reviews, 2010
- AcroBel – the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjectsEuropean Journal of Endocrinology, 2007
- Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and ManagementEndocrine Reviews, 2004